Oncology Strategic Pricing

At AstraZeneca when we see an opportunity for change we seize it and commit real resources to make it happen, because an opportunity no matter how small can be the start of something big. Delivering life-changing medicine is about being entrepreneurial - finding those moments and recognizing their potential.Changing lives means being open and flexible to new ways of doing our work. Astrazeneca is committed to develop Innovative Value Strategies (IVS) to provide more flexibility in reimbursement and funding decisions and ensuring access to our innovative treatments.

As Oncology Strategic Pricing & HEOR Manager your mission will be developed the AZ Strategy of Pricing of all OBU products of AZ Spain in order to provide high quality health economic evidence & innovative pricing models to obtain/maintain national and regional access adequate to product objectives and customer’s needs. Focus on new commercial models and pricing strategy of competitors, to enhance market access uptake. Engages with external partners and internal customers on how innovative pricing approaches can be implemented to create win-win situations between patients, payers and AZ. Contribute to expand the knowledge to move from price to value, incorporating it in tenders and others innovative proposals.

**Responsabilities**:

- Give to develop the P&R Dialogue at National Level
- Lead & develop the Therapeutical Position Report (TPR) process in coordination with the cross-functional teams
- Identify and develop opportunities/risk evaluations of clinical and health-care outcome constructs, and delivering mitigation plans that support markets implementing IVS Frameworks
- Work cross-functionally to ensure consistent use of clinical and health-care outcomes across both IVS agreements and health-economics models and results
- Develop a brand-specific and/or disease area clinical and health-care outcome construct module, which in collaboration with Financial Analyst, IVS will be coordinated into a Global IVS Frameworks Module
- Drive the required payer insights and research to ensure robust and validated P&R approaches.
- Ensure efficient budget planning and secure resources to IVS Frameworks
- Develop the mid/long-term plan and the Pricing strategies for the times/price assumptions of the internal financial exercises (RBU-1/RBU-2/MTP/LTP/Ph.Budget).
- Owns the OBU Pricing & HEOR team that is in charge of HTA assessment at national, regional and hospital level.
- Lead & develop the HTA external partner advocacy plans in collaboration with cross-functional teams
- Pricing regulation monitoring & impact: RPOs, RDL, LoE...
- Leads competitive Intelligence on Pricing
- Give to develop the commercial offers initiatives/ policies achievements strategy that can met in an efficient and timely manner according to the plan and local Working Process/ SoP.
- Anticipated needs, opportunities, and risks, and develop strategies accordantly with Business strategy and market situation.
- Analyze and lead customer and driven insights into strategy development.
- Develop HEOR & Innovative Pricing models & Implement Pricing & HEOR strategies in the Oncology Area.
- Develop health economic models, user interfaces and support materials for use in submissions to reimbursement bodies and by Access Field team with cost-sensitive NHS customers
- Use data from a range of sources (eg clinical audit, databases) and, within cross functional teams, identify the requirement for, and contribute to the development of value messages
- Support technical writing of cost-effectiveness/wider implications sections of submissions to reimbursement bodies
- Develop support materials and provide training in use of health economic value messages for cross-functional and NHS Access Field team.
- Maintain knowledge of Spain reimbursement decision making to find opportunities and potential impact for our Brands
- Develop understanding of what constitutes value to our NHS customers and bring value messages in formats which are impactful, and which aid decision-making
- Partnering with Global Health Economics, IVS & GPI teams to ensure the delivery of health economics projects (e.g. health economic models, detailed reviews, network meta-analyses, costing studies) meet the methodological requirements of HTAs agencies in Spain and according to the local timelines.
- Take ownership for the P&R or HTA dossier preparation and submission to Health authorities, understanding payers’ requirements and needs translating them in high quality health economic evidence, demonstrating results from clinical trials, epidemiological studies, economic models.
- Identify HEOR evidence requirements and gaps, Innovative Pricing Approaches vital to generate data and RWE to support AZ products value demonstration, in coordination with the Evidence Generation Team.
- Product Technical Reports, Economic models and HEOR evidence generation to support product listing at Regional & Hospital levels
- Development of H